170.59
Data as of 3:59pm ET
 -1.84 / -1.07%
Today’s Change
86.95
Today|||52-Week Range
174.49
+53.57%
Year-to-Date
Health Care Select Is Among This Yearo?=o?=o?=s Hottest Health Care ETFs
3:26pm / TheStreet.com
UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce
Jul 21 / Benzinga
Eli Lilly Beats on Q2 Earnings & Revs, Maintains View - Analyst Blog
9:52am / Zacks.com
Stocks: Obama's words soothe markets
Jul 21 / CNNMoney.com
Concord Medical Services Holdings (CCM) Soars: Stock Adds 10.7% in Session - Tale of ...
9:34am / Zacks.com
Mondaybs Top Biotech Stories: Allergan, Anacor, and Sinovac Biotech
Jul 21 / MotleyFool.com
Is Allergan (AGN) Stock a Solid Choice Right Now? - Tale of the Tape
9:18am / Zacks.com
UPDATE: Valeant Complains to SEC Regarding Allergan Claims
Jul 21 / Benzinga
Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog
Jul 23 / Zacks.com
Frontrunning: July 19
Jul 21 / Investing Channel
Zacks Rank #1 Additions for Wednesday - Tale of the Tape
Jul 23 / Zacks.com
Earnings Scheduled For July 21, 2014
Jul 21 / Benzinga
Bayer/Regeneron Continue to Progress with Eylea - Analyst Blog
Jul 22 / Zacks.com
Stocks: 5 things to know before the open
Jul 21 / CNNMoney.com
Earnings Season Boosts Confidence; S&P Trades At Record Highs
Jul 22 / Benzinga
Stocks To Watch For July 21, 2014
Jul 21 / Benzinga
Allergan, a Valeant Takeover Target, Plans 1,500 Job Cuts - Analyst Blog
Jul 22 / Zacks.com
AbbVie Inc. Wins the Shire
Jul 18 / MotleyFool.com
Allergan, Inc. (AGN): New Analyst Report from Zacks Equity Research - Zacks Equity Re...
Jul 22 / Zacks.com
Novartis Misses on Q2 Earnings & Revenue, Outlook Retained - Analyst Blog
Jul 18 / Zacks.com
Shire's Q2 Earnings Strong but Overshadowed by AbbVie Deal - Analyst Blog
Jul 22 / Zacks.com
Pfizer Eyes InnoPharma, Acquisition to Boost Injectables Biz - Analyst Blog
Jul 17 / Zacks.com
Notable Analyst Rating Changes 07/22: (AGN) (RLGY) (FANG) Upgraded; (AMZN) (STI) (MTD...
Jul 22 / Investing Channel
Market Discourages the Best of Us
Jul 17 / TheStreet.com
Company News for July 22, 2014 - Corporate Summary
Jul 22 / Zacks.com
'Fast Money' Recap: What Does Carl Icahn Think?
Jul 17 / TheStreet.com
Allergan Reiterates Plan to Preempt Valeant Offer
Jul 22 / TheStreet.com
Roche Gets Priority Review for Avastin Label Expansion - Analyst Blog
Jul 16 / Zacks.com
Will This Analyst Upgrade Help Allergan (AGN) Stock Today?
Jul 22 / TheStreet.com
Abbott Labs Beats on Q2 Earnings and Sales, Boosts Guidance - Analyst Blog
Jul 16 / Zacks.com
Frontrunning: July 22
Jul 22 / Investing Channel
Why Is Wall Street Bullish on These 3 Stocks?
Jul 15 / MotleyFool.com
Jim Cramer's 'Mad Money' Recap: Don't Panic, Just Wait
Jul 21 / TheStreet.com
Johnson & Johnson Beats on Q2 Earnings, Ups View Again - Analyst Blog
Jul 15 / Zacks.com
Ackman Hints at Herbalifebs (HLF) Enron-like Fraud
Jul 21 / Investing Channel
Shire Meets AbbVie for Acquisition Deal - Analyst Blog
Jul 14 / Zacks.com
Greenberg: Allergan's Dilemma
Jul 21 / TheStreet.com
AbbVie and Shire Close, but Not There Yet
Jul 14 / MotleyFool.com
Allergan Stock Earnings: Good Enough to Fight off Valeant?
Jul 21 / MotleyFool.com
Abbott Labs, Fonterra Collaborate for Dairy Farm Hub in China - Analyst Blog
Jul 11 / Zacks.com
Regional banks slip after BB&T setback
Jul 21 / FT.com
Shire in talks with US drugmaker AbbVie over B#30bn bid
Jul 11 / FT.com
3 Stocks Moving The Health Care Sector Upward
Jul 21 / TheStreet.com
Is AbbVie's Revised Offer for Shire Finally Enough?
Jul 10 / MotleyFool.com
Allergan Beats on Q2 Earnings, Ups View & Plans 13% Job Cut - Analyst Blog
Jul 21 / Zacks.com
3 Pharma Stocks to Watch: Allergan, Valeant, and AbbVie
Jul 10 / MotleyFool.com
Jim Cramer's Thoughts on ADP (ADP), BP (BP) and Time Warner (TWX) Stock
Jul 21 / TheStreet.com
Top Biotech Stocks to Watch Today: Allergan, Arena Pharmaceuticals and Bristol-Myers ...
Jul 10 / MotleyFool.com
Allergan to cut 1,500 jobs as it fights Valeant takeover bid
Jul 21 / FT.com
Investors press Allergan to find deal
Jul 09 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.